CLEVELAND-CLIFFS INC (CLF)
US1858991011 - Common Stock
Overall CLF gets a fundamental rating of 2 out of 10. We evaluated CLF against 155 industry peers in the Metals & Mining industry. CLF has a bad profitability rating. Also its financial health evaluation is rather negative. CLF has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CLF has reported negative net income.
In the past year CLF had a positive cash flow from operations.
CLF had positive earnings in 4 of the past 5 years.
CLF had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CLF's Return On Assets of -2.75% is in line compared to the rest of the industry. CLF outperforms 43.23% of its industry peers.
CLF has a worse Return On Equity (-6.74%) than 62.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.75% | ||
| ROE | -6.74% | ||
| ROIC | N/A |
ROA(3y)8.38%
ROA(5y)6.55%
ROE(3y)25.54%
ROE(5y)30.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of CLF has declined.
In the last couple of years the Operating Margin of CLF has declined.
CLF has a worse Gross Margin (2.56%) than 63.87% of its industry peers.
CLF's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CLF so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.56% |
OM growth 3Y3.41%
OM growth 5Y-34.19%
PM growth 3YN/A
PM growth 5Y-48.14%
GM growth 3Y-10.8%
GM growth 5Y-28.89%
2. Health
2.1 Basic Checks
CLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLF has been reduced compared to 1 year ago.
Compared to 5 years ago, CLF has more shares outstanding
CLF has a better debt/assets ratio than last year.
2.2 Solvency
CLF has an Altman-Z score of 1.77. This is a bad value and indicates that CLF is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLF (1.77) is worse than 61.94% of its industry peers.
CLF has a debt to FCF ratio of 6.57. This is a slightly negative value and a sign of low solvency as CLF would need 6.57 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.57, CLF is in the better half of the industry, outperforming 65.16% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that CLF is somewhat dependend on debt financing.
CLF's Debt to Equity ratio of 0.55 is on the low side compared to the rest of the industry. CLF is outperformed by 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.57 | ||
| Altman-Z | 1.77 |
ROIC/WACCN/A
WACC10.58%
2.3 Liquidity
A Current Ratio of 1.85 indicates that CLF should not have too much problems paying its short term obligations.
CLF has a worse Current ratio (1.85) than 61.29% of its industry peers.
CLF has a Quick Ratio of 1.85. This is a bad value and indicates that CLF is not financially healthy enough and could expect problems in meeting its short term obligations.
CLF has a worse Quick ratio (0.55) than 89.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.55 |
3. Growth
3.1 Past
CLF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -158.21%.
CLF shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
The Revenue has decreased by -8.92% in the past year.
The Revenue has been growing by 56.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-158.21%
EPS 3YN/A
EPS 5Y-19.03%
EPS Q2Q%-200%
Revenue 1Y (TTM)-8.92%
Revenue growth 3Y60.16%
Revenue growth 5Y56.65%
Sales Q2Q%-18.48%
3.2 Future
The Earnings Per Share is expected to grow by 2.34% on average over the next years.
The Revenue is expected to decrease by -0.78% on average over the next years.
EPS Next Y-170.41%
EPS Next 2Y-58.07%
EPS Next 3Y2.34%
EPS Next 5YN/A
Revenue Next Year-11.16%
Revenue Next 2Y-3.28%
Revenue Next 3Y-0.53%
Revenue Next 5Y-0.78%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CLF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 51.64, the valuation of CLF can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLF is on the same level as its industry peers.
CLF is valuated expensively when we compare the Price/Forward Earnings ratio to 24.00, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 51.64 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLF indicates a somewhat cheap valuation: CLF is cheaper than 62.58% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CLF is valued cheaply inside the industry as 92.26% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.05 | ||
| EV/EBITDA | 9.6 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-58.07%
EPS Next 3Y2.34%
5. Dividend
5.1 Amount
CLF does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CLEVELAND-CLIFFS INC
NYSE:CLF (12/26/2024, 8:04:33 PM)
Premarket: 9.355 +0.01 (+0.05%)9.35
-0.11 (-1.16%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners73.94%
Inst Owner Change2.57%
Ins Owners1.63%
Ins Owner Change0.16%
Market Cap4.62B
Analysts65.88
Price Target14.45 (54.55%)
Short Float %9.1%
Short Ratio3.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)-44.93%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.54%
Min EPS beat(2)-90.92%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)2.72%
Min EPS beat(4)-90.92%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)4.32%
EPS beat(12)5
Avg EPS beat(12)-3.61%
EPS beat(16)6
Avg EPS beat(16)-11.84%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-5.15%
Max Revenue beat(2)-3.12%
Revenue beat(4)0
Avg Revenue beat(4)-3.34%
Min Revenue beat(4)-5.15%
Max Revenue beat(4)-1.41%
Revenue beat(8)2
Avg Revenue beat(8)-1.85%
Revenue beat(12)4
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-1.27%
PT rev (1m)-3.05%
PT rev (3m)-12.26%
EPS NQ rev (1m)-13.66%
EPS NQ rev (3m)-462.02%
EPS NY rev (1m)-41.09%
EPS NY rev (3m)-492.85%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-13.71%
Revenue NY rev (1m)-1.22%
Revenue NY rev (3m)-3.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 51.64 | ||
| P/S | 0.23 | ||
| P/FCF | 8.05 | ||
| P/OCF | 3.76 | ||
| P/B | 0.67 | ||
| P/tB | 0.82 | ||
| EV/EBITDA | 9.6 |
EPS(TTM)-0.39
EYN/A
EPS(NY)0.18
Fwd EY1.94%
FCF(TTM)1.16
FCFY12.43%
OCF(TTM)2.49
OCFY26.61%
SpS40.43
BVpS13.88
TBVpS11.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.75% | ||
| ROE | -6.74% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.56% | ||
| FCFM | 2.87% |
ROA(3y)8.38%
ROA(5y)6.55%
ROE(3y)25.54%
ROE(5y)30.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.85%
ROCE(5y)11.98%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3.41%
OM growth 5Y-34.19%
PM growth 3YN/A
PM growth 5Y-48.14%
GM growth 3Y-10.8%
GM growth 5Y-28.89%
F-Score3
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.57 | ||
| Debt/EBITDA | 4.34 | ||
| Cap/Depr | 70.58% | ||
| Cap/Sales | 3.28% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 141.26% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.55 | ||
| Altman-Z | 1.77 |
F-Score3
WACC10.58%
ROIC/WACCN/A
Cap/Depr(3y)78.73%
Cap/Depr(5y)231.51%
Cap/Sales(3y)3.5%
Cap/Sales(5y)10.48%
Profit Quality(3y)195.58%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-158.21%
EPS 3YN/A
EPS 5Y-19.03%
EPS Q2Q%-200%
EPS Next Y-170.41%
EPS Next 2Y-58.07%
EPS Next 3Y2.34%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.92%
Revenue growth 3Y60.16%
Revenue growth 5Y56.65%
Sales Q2Q%-18.48%
Revenue Next Year-11.16%
Revenue Next 2Y-3.28%
Revenue Next 3Y-0.53%
Revenue Next 5Y-0.78%
EBIT growth 1Y-109.68%
EBIT growth 3Y65.62%
EBIT growth 5Y3.09%
EBIT Next Year19.25%
EBIT Next 3Y34.52%
EBIT Next 5Y21.51%
FCF growth 1Y-72.96%
FCF growth 3YN/A
FCF growth 5Y41.39%
OCF growth 1Y-59.98%
OCF growth 3YN/A
OCF growth 5Y35.54%